Abbott follows rival Dexcom with OTC glucose monitor launch in US
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Abbott Laboratories (NYSE: ABT) | Delayed: 109.58 -0.58 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $110.16 | 52 Week High | $46.38 | |||
| Open | $109.36 | 52 Week Low | $36.00 | |||
| Day High | $110.62 | P/E | 73.05 | |||
| Day Low | $109.08 | EPS | $1.50 | |||
| Volume | 938,633 | |||||
